Clinical Value of Preoperative Oral Carbohydrate Loading in Colorectal Surgery

March 9, 2015 updated by: Mehmet Fatih Can, Gulhane School of Medicine

Multi-centre Double-blind Randomized Trial of the Clinical Value of Preoperative Oral Carbohydrate Loading in Colorectal Surgery.

The aim of this study is to provide conclusive clinical evidence as to whether or not the preoperative administration of oral carbohydrate-rich solutions is effective on the outcomes of patients undergoing colorectal surgery.

Study Overview

Detailed Description

Preoperative oral carbohydrate loading is an issue that has been investigated extensively in terms of its fundamental and biochemically apparent effects and potential benefits. Most commonly, proponents of the application advocate that it may be beneficial for improving patient outcomes and for decreasing complication rate by attenuating postoperative insulin resistance. To date, however, no study with a sufficient sample size has been able to demonstrate that it has a marked value in clinical practice. Almost all of the clinical benefits ascribed to the application have been based on subjective well-being, which can also be provided with non specific simple beverages. A study conducted to show whether or not the application has direct influence on patient outcome, therefore, could significantly contribute insights on this topic. The present study was planned to consist of three study arms, namely: 1.Study group, which will be given high-carbohydrate beverage (Nutricia preOp®, Numico, Zoetermeer, The Netherlands) 2. Placebo group, which will be given flavored water, and 3. Control group (surgery after overnight fast). The revised power analysis shows that an accrual of 74 patients in each group would allow detecting a 15% difference in the rate of complications with 80% power at the 5% level of significance (two tailed). We hope we will have recruited at least 220 subjects at the end of a two-year course. Once the data recording is complete, this study will be the largest one ever conducted to investigate this topic.

Study Type

Interventional

Enrollment (Actual)

215

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06018
        • Gulhane School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 80 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients undergoing colorectal surgery for malignant or benign diseases

Exclusion Criteria:

  • diabetes
  • disorders that prolongs gastric emptying
  • existence of an increased risk for aspiration of gastric content
  • anal surgery (haemorrhoidectomy, fistulotomy...etc)
  • emergency operations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: 2
Placebo
will be given in doses equal to those of high-carbohydrate beverage
No Intervention: 3
Control
Experimental: 1
High-carbohydrate
800 ml before the day of surgery, and additional 400 ml two hours prior to surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Overall 30-day complication rate
Time Frame: 2 years
2 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Patient discomfort
Time Frame: 2 years
2 years
need for insulin infusion
Time Frame: 2 years
2 years
Length of intensive care unit and hospital stay
Time Frame: 2 years
2 years
Patient recovery
Time Frame: 2 years
2 years
Overall 30-day mortality rate
Time Frame: 2 years
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mehmet F Can, Assist Prof, Gulhane School of Medicine, Department of Surgery
  • Principal Investigator: Avdyl Krasniqi, MD, PhD, University Clinical Centre of Kosova, Department of Surgery
  • Principal Investigator: Costas Vagianos, Assoc Prof, Agios Panteleimon Regional Hospital, Deparment of Surgery
  • Principal Investigator: Gokhan Yagci, Assoc Prof, Gulhane School of Medicine, Department of Surgery
  • Principal Investigator: Gyorgy Lazar, Prof, University of Szeged, Department of Surgery
  • Principal Investigator: Wim P Ceelen, MD, PhD, Prof, Ghent University Hospital, Department of Surgery

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2009

Primary Completion (Actual)

May 1, 2012

Study Completion (Actual)

May 1, 2012

Study Registration Dates

First Submitted

March 24, 2009

First Submitted That Met QC Criteria

March 24, 2009

First Posted (Estimate)

March 25, 2009

Study Record Updates

Last Update Posted (Estimate)

March 10, 2015

Last Update Submitted That Met QC Criteria

March 9, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • PRECALICS

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Disorders

Clinical Trials on commercially available high-carbohydrate beverage

3
Subscribe